BioSpace News Archive

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announces grants totaling nearly $5 million to three teams expanding genetic research in international Parkinson’s disease populations.

Physicians featuring point-of-care education on opioids and opioid addiction are distributing fewer opioids than the national average, according to new data released today from patient engagement leader PatientPoint® and national nonprofit Shatterproof™.

Ivy Rehab Physical Therapy (Ivy) continues to rapidly expand its footprint, with six new clinics being added to the Ivy Rehab Network of physical and occupational therapy practices in recent weeks.

ATL Technology today announced it has named John Scadden as the Chief Financial Officer of the company

Newport Academy, a series of leading adolescent and young adult treatment centers specializing in mental health, trauma, eating disorders, and substance use disorder, has announced its in-network status with major insurers like Anthem Blue Cross in California, a development that helps address America’s growing mental health needs.

Today, the Lupus Foundation of America announced six recipients of the 2019 Gina M. Finzi Memorial Student Summer Fellowship Program which was developed to cultivate an interest in lupus research among young scientists.

First-of-its-kind research study shows increased emergency department workload to treat cannabis overdoses

InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, will participate in the 5CC (5 Continent-Congress) in the field of medical and aesthetic dermatology.

Cano Health, LLC, which operates medical centers and pharmacies in Florida that specialize in primary care for Seniors, is ranked number one as the fastest-growing healthcare company - and number six across all industries by Inc. magazine’s annual 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies.

AscellaHealth, a national Pharmacy Benefit Management (PBM) serving commercial, Medicare and Medicaid segments, is proud to announce that Dea Belazi, PharmD, MPH, president and CEO, AscellaHealth, will join industry luminaries on FierceHealthcare’s inaugural Editorial Advisory Council.